C-FINDS C

Welcome to the Brand page for “C-FINDS C”, which is offered here for Planning, management or convening of academic conferences, academic meetings, academic lecture meetings and symposiums; planning, management and convening of forums and exhibitions related to medicine and medical care; planning, management and convening of seminars in the field of oncology; production and publication of books; education and training in the fields related to cancer; planning, management or convening of award ceremonies;the mark consists of the wording c-finds in gray lettering below a blue stylized letter c which contains a large blue oval inside of the c that is connected to a small blue oval on the right outside of the c. both ovals have ovals inside them on the upper left side that contain a shaded region with a white dot in its center.;providing scholarship fund, providing fundraising activities, funding, scholarships and/or financial assistance for promotion of scientific research and graduate students or postgraduate research students belonging to university research institutes in japan; providing scholarship loans; providing incentive scholarship for overseas education; providing research grants in medical field; providing research grants and research incentives for basic and applied researches on pharmacotherapy and drug discovery and development of new drugs; charitable foundation services, providing financial support for sending researchers to international conferences; charitable foundation services, providing financial support and subsidies for inviting overseas researchers and scholarship support fund for graduate students; charitable fundraising;the color(s) blue, gray and white is/are claimed as a feature of the mark.;providing medical information related to cancer treatment and anti-cancer agents; providing medical information on clinical trials related to cancer; providing medical information related to cancer research;.

Its status is currently believed to be active. Its class is unavailable. “C-FINDS C” is believed to be currently owned by “Tokyo Biochemical Research Foundation”.